Growth-enhanced fish can be competitive in the wild

Abstract

1. The widespread commercial interest in producing growth-enhanced organisms has raised concerns about ecological consequences, emphasizing the need to understand the costs and benefits associated with accelerated growth in nature. Here, sustained-release growth hormone (GH) implants were used to estimate the competitive ability of growth-enhanced fish in the wild. Growth rate, movements and survival over winter were compared between GH-implanted and control Brown Trout in a natural stream. The study was repeated over two consecutive years. 2. GH treatment had no effect on recapture rates, indicating that mortality rates did not differ between GH-treated and control fish. More GH-treated trout (63%) than control fish (41%) were recaptured within their 10 m section of release. Thus, GH-treated fish were more stationary than control fish over winter. 3. GH-treated fish grew about 20% faster than control fish. This was mainly because of a three-fold growth rate increase in GH-treated fish in late summer, whereas growth rates over winter did not differ significantly between treatment groups. These results were consistent over both replicate years. 4. This first study of growth-enhanced fish in the wild shows that they can survive well and therefore may out-compete normal fish with lower growth rates. Although selection against rapid growth may be more intense at other life-history stages and/or during periods of extreme climate conditions, our findings raise concerns that released or escaped growth-enhanced salmonids may compete successfully with resident fish. It is clear that the potential ecological risks associated with growth-enhanced fish should not be ignored.